Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
David B. Sarwer, Professor of Social and Behavioral Sciences, Temple University

Making GLP-1 weight loss drugs cheaper isn’t enough to address America’s obesity problem – here’s why

Polling shows that 1 in 8 Americans have tried GLP-1 drugs. zimmytws/iStock via Getty Images Plus

The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, 2025, will reduce the monthly prices of these medications by hundreds of dollars.

For the past 25 years, I have treated people with obesity and have developed and studied treatments for the condition in both adults and adolescents. One major frustration of my work is the fact that evidenced-based treatments for obesity are woefully underused

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.